## 

## 



## 

## 

|||Contents||
|---|---|---|---|
|Charity information||||
|Report ofthe Trustees|||2-7|
|Independent<br>Auditor's|Report||8-10|
|Statement ofFlnanciai|Activities|||
|Salance Sheet||||
|Statement<br>of Cash Flaws||||
|Notes to the Financial|Statements||14-22|





## 

## 

## 

|Barclays Bank|Barclays Bank|pic|pic|
|---|---|---|---|
|One Churchill||Place||
|London||||
|E14SHP||||
|Nationwide|Building Society|||
|Kings Park|Road|||
|Moulton<br>Park||||
|Norlhampton||||
|NN3 6NW||||
|Newbury<br>Building|||Society|
|17Bartholomew|||Street|
|Newbury||||
|RG14 5LY||||
|Seven Brlttan||||
|35Colston|Avenue|||
|Bristol||||
|BS14TT||||
|UHY Ross|Brooke|||
|Suite I||||
|Windrush<br>Court||||
|Abingdon<br>Business Park||||
|Abingdon||||
|OX14 1SY||||





## 

## 

## 



# 

## 

## 

## 



## 

## 

## 

## 

## 



# 

## 

## 

|s<br>stees who held oNce and wh|o are all Directors ofthe company wer|
|---|---|
|Sarah Deal||
|Dr Keith Endersby|Secretary|
|Sylvia Galbraith||
|Victoria Hopgood||
|Shane Prater||
|Richard Rudgely|(appointed 27 April 2023)|
|Dr Robert Tayton|Chairman|
|Paul Townsend||



## 

|Key Exec|udves end Prof|essional Advisers||
|---|---|---|---|
|Chairman:||Dr Robert Taytcn||
|Company|Secretary:|Dr Keith Endersby||
|Bankers:||Bardays Bank pic and Nationwide|Building Society|
|Solicitors:||Seven Brittan||
|Auditors:||UHY Ross Brooks||





# 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

||||2023|2023|2023|2022|
|---|---|---|---|---|---|---|
|||Notes|Unrestricted|Restricted|Total|Total|
||||Funds|Funds|Funds|Funds|
||||8||8||
|||||||(Nore f8)|
|INCOME AND ENDOWMENTS<br>Donations snd legacies|FROM;|||36,914|36,914|I38,083|
|Income from charitable<br>activities<br>Provision ofhospital services<br>Investment<br>income|||5,474,302||5,474,302<br>~LRS|5.280,885|
|TOTAL|||'M6%%59|&Rial|~634B|'&~M|
|EXPENDITURE ON:|||||||
|Charitable<br>Activities:<br>Cost ofhospital services —contractual<br>Cost ofhospital services -voluntary|||4,948,813<br>~27 ru|~46|4,948,813<br>~344%|4,770.945|
|TOTAL||4|~22~2|AILU)5|~AEK2B|5~2K|
|NET INCOME/(EXPENDITURE)<br>BEFORETRANSFERS|||382,413|(9,251)|373,162|380,099|
|Transfers between funds||14|||||
|Net income/(expenditure)<br>snd net<br>movement<br>in funds in the year<br>Total funds st 1 October 2022|||382,4'l3<br>rL2g5 954|(9,251)<br> ~~1|373,162<br>9rU2,202|380,099<br> ~~~08|
|Total funds st 30September 2023|||||||





## 

|||Notes|||2023|2023||2022|
|---|---|---|---|---|---|---|---|---|
|CURRENT ASSETS|||||||||
|Debtors:|||||||||
|Falling due within one year<br>Falling due after more than one year<br>Cash at bank and in hand||7<br>8||1,449,557<br>7,945,315<br>~LEER||||1.372.245<br>8.817,015<br>~8X1H|
|||||19,041,725||||18.832.428|
|CREDITORS: Amounts<br>one year|falling due within|9|~5~7718|||||~1229923|
|NET CURRENT ASSETS||||||17,784,009||17.604,405|
|CREDITORS: Amounts|falling due after more||||||||
|than one year||10|||||(6,348,683)|(7,096,845j|
|Provisions<br>for liabilities|snd charges|||||~1959959||~1 "~235|
|TOTAL ASSETS LESSLIABILITIES|||||||||
|Unrestricted<br>funds||13|||||9,588,367|9,205,954|
|Restricted<br>funds||14||||||9251|
|TOTAL FUNDS||15||||~~K||~~05|
|Approved<br>and authorised|for issue by the Board|ofTrustees||on|Q.SI|/|5720P+ and|signed on their|
|behalf by|||||||||
|Q &<br>&-tr=|||||||||
|RTsyton|||||||||
|Chairman<br>ofTrustees|||||||||





## 

## 

||||2023|2022|
|---|---|---|---|---|
||||8||
|Cash flows from operating<br>activities:|||||
|Net movement<br>in funds|||373,182|380,099|
|Amortlsstion<br>offinance receivable|||835,700|799,459|
|interest received|||(132,218)|(14,927)|
|Interest paid|||493,913|530,398|
|Decrease/(increase)/in<br>debtors|||(41,312)|892,798|
|Increase/(decrease)<br>in creditors<br>Increase/(decrease)<br>in provisions|||(48,198)<br>~KSB|79,982<br>~88447|
|Net cash provided by operating<br>activities|||M~07Si|~dk12B)|
|Cash flows from Investing<br>activities<br>interest received|||~227|~14<br>7|
|Net cash provided by investing<br>activities|||||
|Cash flows from Bnancing activities|||||
|Interest paid<br>Repayment<br>ofloan|||(493,913)<br>~672<br>71|(530.398)<br>~787868|
|Net cash used in by financing<br>activities|||~8~84|~+I~83 Q|
|Change<br>in cash and cash equivalents<br>in the <br>Cash and cash equivalents<br>atthe beginning||year<br>ofthe year|1,003,885<br>8642188|1,127,923<br>m8tL8~|
|Total cash and cash equivalents<br>atthe|end|ofthe year|||
||||2023|2022|
|Analysis ofcash and cash equivalents:|||2||
|Cash st bank and in hand|||||





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



# 

## 

## 

## 

## 

## 

## 



## 

|3,|DONATIONS<br>AND LEGACIES||2023|2022|
|---|---|---|---|---|
||||8|9|
||Other donations||~ae<br>14|~ae 242|
||In 2023 and 2022 the donations<br>received by the Charity were restricted.||||
||EXPENDITURE||||
||||2023|2022|
||Charitable Activities:||8||
||Cost ofhospital services -contractual<br>Facilities management<br>charge<br>Management<br>fees<br>Sinking<br>fund expenditure<br>Model update<br>Amortisation<br>offinance receivable||2,821,339<br>118,050<br>180,028<br>6,600<br>SSO,S9O|2,393,146<br>95,220<br>525,787<br>6,600<br>794,486|
||Loan interest||493,913|530,398|
||Insurance||87,205|56,170|
||Variation<br>expenditure<br>recharged<br>Amortisation<br>ofloan arrangement<br>Utility charge<br>Governance<br>Other costs|fees|171,743<br>5,310<br>430,817<br>12,850<br>~LEL0|12,836<br>4,973<br>327,697<br>11,500<br>~1222|
||||4,948,813|4,770945|
||Cost of hospital services —voluntary<br>Variation expenditure<br>met by Charity<br>MRI legal and professional<br>costs||2S2,004<br>~SS 2<br>321,4SS|282,851<br>282,851|





## 

|2023|2022|
|---|---|
|8|6|



## 

## 

|7.|DEBTORS;Amounts|falling due within one year|falling due within one year|falling due within one year|||
|---|---|---|---|---|---|---|
|||||||2022|
|||||||2|
||Finance receivable<br>Prepayments<br>and accrued income||||871,700<br>577 857|835,700<br>~58854|
|8.|DEBTORS:Amounts|falling due after more than one year|||||
||||||2023|2022|
|||||||6|
||Finance receivable||||||
|8.|CREDITORS: Amounts||falling due within|one year|||
||||||2023|2022|
||||||8||
||Building Society - loan||capital repayable|within one year|748,162|672,271|
||Trade creditors||||276,670|328.642|
||Social Security and|other taxes|||118,715|116,467|
||Other creditors|||||9.355|
||Accruals||||114199|181288|





## 

|REDITORS: Amounts<br>falling due after more than|one year||
|---|---|---|
||2023|2022|
||8||
|Building Society loan capital due:<br>in one —two years<br>In two —five years<br>In more than five years|843,327<br>3,880,836|748,f53<br>3,001,163<br>~351st|



## 

## 

|Life Cycle and Maintenance||
|---|---|
|At 1 October 2022|1„282,355|
|Additions<br>Amounts<br>used|734,626<br>~tjIJQS|
|At 30September 2023||



## 

## 



## 






## 

## 

|ANALYSIS OF NET ASSETS|ANALYSIS OF NET ASSETS|ANALYSIS OF NET ASSETS|BETWEEN FUNDS|BETWEEN FUNDS||||
|---|---|---|---|---|---|---|---|
|2023|||Net current<br>assets|Long term<br>liability|Provisions|Transfers|Total<br>2023|
||||8|8|8|6|8|
|Unrestricted|—General|fund|17,784,009|(6,348,683)|(1,848,959)||9,688,367|
|Unrestricted|—Designated|||||||
|Restricted||||||||
||||1Z784,0~0.|(634(L663)|{1~8535%9||- ~II~|
|2022|||fVet current<br>assets|Long term<br>liability|Provisions|Transfers|Total<br>2022|
|||||8|6|8|6|
|Unrestricted-<br>Unrestncted <br>Restncted|General fund<br> —Designated||17,403,936<br>191,218<br>~9|(7,096,845)|(f,292,355)||9,014, 736<br>191,218|



## 

## 

||Financial assets an|d liabilit|ies|measured<br>at fa|ir value sre finan|ce receivable and pr|ovisions.|
|---|---|---|---|---|---|---|---|
||||||||2022|
||Financial assets measured|||at fair value||8,817,014|9,652,715|
||Financial<br>liabilities|measured||atfair value||4154LII5$||
|17.|ANALYSIS OF CHANGES||IN NET DEBT|||||
|||||01Oct|Cash-flows|Other non-cash|30Sep|
|||||2022||changes<br>6|2023<br>8|
||Cash|||8,643, 168|1,003,685||9,848,853|
||Finance<br>receivable|due||635,700|(835,700)|871,700|871,700|
||within one year<br>Finance receivable|after||8,817,015||(871,700)|7,946,315|
||more than one year<br>Loans falling<br>due<br>within|||(672,271)|672,271|(748,162)|(748,162)|
||one year<br>Loans<br>falling<br>due|after|~~~6845|||~7(LL82|~8~8683|
||more than one year|||||||
||Total|||||||





## 


||||2022|2022|2022|
|---|---|---|---|---|---|
||Notes|UnrestrIcted||Restricted|Total|
|||Funds||Funds|Funds|
|||||8||
|INCOME AND ENDOWMENTS FROM:||||||
|Donations and legacies||||138,083|138,083|
|Income from chantable<br>activities||||||
|Provision ofhospital services||5.280,885|||5.2eo,ee5|
|Investment<br>income|||74847|80|74 227|
|TOTAL||~5|5~7|f38'I83|5499!85|
|EXPENDITURE ON:||||||
|Charitable<br>Activities:||||||
|Cost ofhospital services —contractual||4,770,945|||4,770,945|
|Cost ofhospital services - voluntary|||744 7II8|738029|282 85t|
|TOTAL|4|~~OZf2||~II~0|~~ZÃ|
|NET INCOMFJ(EXPENDITURE)||||||
|BEFORETRANSFERS|||380,019|80|380,099|
|Transfers<br>betvveen<br>funds|14|||||
|Netincomef(ettpendtture)<br>and net||||||
|movementin<br>fundsin<br>the year|||380,019|eo|eeo,ogg|
|Total funds at 1October 2021||~8|~ 5II5|9fft|~883570|
|Total funds at30September 2022||~gam||m8|~~00|



